Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

Kelly Posner, Gregory K. Brown, Bárbara Stanley et al. · American Journal of Psychiatry · 2011 · 5K citations

Social Sciences, Psychiatry, Psychology +15

World Alzheimer Report 2015 - The Global Impact of Dementia:An analysis of prevalence, incidence, cost and trends

Martin Prince, Anders Wimo, Maëlenn Guerchet et al. · HAL (Le Centre pour la Communication Scientifique Directe) · 2015 · 2.3K citations · Full text

Medicine, Geriatric Medicine, Neurology +14

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway, Reisa A. Sperling, Nick C. Fox et al. · New England Journal of Medicine · 2014 · 2K citations · Full text

Medicine, Neurology, Pharmacology +17

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Medicine, Neurology, Neuroscience +14

Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme

Nibaldo C. Inestrosa, Alejandra Álvarez, Cristián A. Pérez et al. · Neuron · 1996 · 1.1K citations · Full text

Life Sciences, Biochemistry, Neuroscience +17